Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Abstract: Obstructive Sleep Apnea remains a critical yet underdiagnosed sleep disorder, with current diagnostic methods often being invasive, costly, or inaccessible. This study introduces an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results